ATTO(ATTO)
ATTO
$18.52—Stale · unknown old
NYSE • Last print unknown ago
$18.52—Stale · unknown old
| Date | Insider | Title | Type | Price | Shares | Value | Owned After |
|---|---|---|---|---|---|---|---|
| Aug 5, 26 | WALSH COLIN | CTO | Purchase | -- | 5.74K | -- | 105.81K |
| Aug 5, 26 | WALSH COLIN | CTO | Purchase | -- | 11.40K | -- | 100.06K |
| Aug 5, 26 | WALSH COLIN | CTO | Purchase | -- | 45.59K | -- | 88.67K |
| Aug 5, 26 | WALSH COLIN | CTO | Purchase | -- | 11.49K | -- | 43.08K |
| Aug 5, 26 | WALSH COLIN | CTO | Purchase | -- | 28.72K | -- | 31.59K |
| Aug 5, 26 | WALSH COLIN | CTO | Purchase | -- | 2.87K | -- | 2.87K |
| Aug 5, 26 | GOLDMAN SACHS GROUP INC | 10% Owner | Purchase | -- | 5.74K | -- | 105.81K |
| Aug 5, 26 | GOLDMAN SACHS GROUP INC | 10% Owner | Purchase | -- | 11.40K | -- | 100.06K |
| Aug 5, 26 | GOLDMAN SACHS GROUP INC | 10% Owner | Purchase | -- | 45.59K | -- | 88.67K |
| Aug 5, 26 | GOLDMAN SACHS GROUP INC | 10% Owner | Purchase | -- | 11.49K | -- | 43.08K |
| Aug 5, 26 | GOLDMAN SACHS GROUP INC | 10% Owner | Purchase | -- | 28.72K | -- | 31.59K |
| Aug 5, 26 | GOLDMAN SACHS GROUP INC | 10% Owner | Purchase | -- | 2.87K | -- | 2.87K |
| Aug 6, 26 | WALSH COLIN | CTO | Purchase | $17.00 | 500.00K | $8.50M | 3.02M |
| Aug 6, 26 | WALSH COLIN | CTO | Purchase | -- | 478.50K | -- | 2.52M |
| Aug 6, 26 | WALSH COLIN | CTO | Purchase | -- | 1.96M | -- | 2.04M |
| Aug 5, 26 | WALSH COLIN | CTO | Purchase | $21.00 | 85.00K | $1.78M | 85.00K |
| Aug 5, 26 | WALSH COLIN | CTO | Sale | $22.03 | 988 | $21.77K | 84.01K |
| Aug 5, 26 | WALSH COLIN | CTO | Sale | $21.87 | 447 | $9.78K | 83.56K |
| Aug 5, 26 | WALSH COLIN | CTO | Sale | $22.03 | 1.33K | $29.34K | 82.23K |
| Aug 5, 26 | WALSH COLIN | CTO | Sale | $22.05 | 200 | $4.41K | 82.03K |
| Aug 5, 26 | WALSH COLIN | CTO | Sale | $22.06 | 1.56K | $34.33K | 80.48K |
| Aug 5, 26 | WALSH COLIN | CTO | Sale | $22.02 | 3.40K | $74.91K | 77.08K |
| Aug 5, 26 | WALSH COLIN | CTO | Sale | $22.10 | 200 | $4.42K | 76.88K |
| Aug 5, 26 | WALSH COLIN | CTO | Sale | $21.55 | 480 | $10.34K | 76.39K |
| Aug 5, 26 | WALSH COLIN | CTO | Sale | $22.11 | 100 | $2.21K | 76.30K |
| Aug 5, 26 | WALSH COLIN | CTO | Sale | $21.97 | 753 | $16.54K | 75.54K |
| Aug 5, 26 | WALSH COLIN | CTO | Sale | $22.02 | 672 | $14.80K | 74.87K |
| Aug 5, 26 | WALSH COLIN | CTO | Sale | $22.03 | 6.97K | $153.55K | 67.90K |
| Aug 5, 26 | WALSH COLIN | CTO | Sale | $22.02 | 400 | $8.81K | 67.50K |
| Aug 5, 26 | WALSH COLIN | CTO | Sale | $21.84 | 1.18K | $25.77K | 66.32K |
| Aug 5, 26 | WALSH COLIN | CTO | Sale | $22.05 | 1.04K | $22.93K | 65.28K |
| Aug 5, 26 | WALSH COLIN | CTO | Sale | $20.84 | 300 | $6.25K | 64.98K |
| Aug 5, 26 | WALSH COLIN | CTO | Sale | $21.78 | 443 | $9.65K | 64.54K |
| Aug 5, 26 | WALSH COLIN | CTO | Sale | $22.05 | 200 | $4.41K | 64.34K |
| Aug 5, 26 | WALSH COLIN | CTO | Sale | $22.07 | 700 | $15.45K | 63.64K |
| Aug 5, 26 | WALSH COLIN | CTO | Sale | $22.19 | 1.16K | $25.81K | 62.47K |
| Aug 5, 26 | WALSH COLIN | CTO | Sale | $21.99 | 100 | $2.20K | 62.37K |
| Aug 5, 26 | WALSH COLIN | CTO | Sale | $21.61 | 6.76K | $146.15K | 55.61K |
| Aug 5, 26 | WALSH COLIN | CTO | Sale | $21.04 | 76.42K | $1.61M | -- |
| Aug 6, 26 | WALSH COLIN | CTO | Sale | -- | 18.18M | -- | -- |
| Aug 6, 26 | WALSH COLIN | CTO | Sale | -- | 4.45M | -- | -- |
| Aug 6, 26 | GOLDMAN SACHS GROUP INC | 10% Owner | Purchase | $17.00 | 500.00K | $8.50M | 3.02M |
| Aug 6, 26 | GOLDMAN SACHS GROUP INC | 10% Owner | Purchase | -- | 478.50K | -- | 2.52M |
| Aug 6, 26 | GOLDMAN SACHS GROUP INC | 10% Owner | Purchase | -- | 1.96M | -- | 2.04M |
| Aug 5, 26 | GOLDMAN SACHS GROUP INC | 10% Owner | Purchase | $21.00 | 85.00K | $1.78M | 85.00K |
| Aug 5, 26 | GOLDMAN SACHS GROUP INC | 10% Owner | Sale | $22.03 | 988 | $21.77K | 84.01K |
| Aug 5, 26 | GOLDMAN SACHS GROUP INC | 10% Owner | Sale | $21.87 | 447 | $9.78K | 83.56K |
| Aug 5, 26 | GOLDMAN SACHS GROUP INC | 10% Owner | Sale | $22.03 | 1.33K | $29.34K | 82.23K |
| Aug 5, 26 | GOLDMAN SACHS GROUP INC | 10% Owner | Sale | $22.05 | 200 | $4.41K | 82.03K |
| Aug 5, 26 | GOLDMAN SACHS GROUP INC | 10% Owner | Sale | $22.06 | 1.56K | $34.33K | 80.48K |
| Aug 5, 26 | GOLDMAN SACHS GROUP INC | 10% Owner | Sale | $22.02 | 3.40K | $74.91K | 77.08K |
| Aug 5, 26 | GOLDMAN SACHS GROUP INC | 10% Owner | Sale | $22.10 | 200 | $4.42K | 76.88K |
| Aug 5, 26 | GOLDMAN SACHS GROUP INC | 10% Owner | Sale | $21.55 | 480 | $10.34K | 76.39K |
| Aug 5, 26 | GOLDMAN SACHS GROUP INC | 10% Owner | Sale | $22.11 | 100 | $2.21K | 76.30K |
| Aug 5, 26 | GOLDMAN SACHS GROUP INC | 10% Owner | Sale | $21.97 | 753 | $16.54K | 75.54K |
| Aug 5, 26 | GOLDMAN SACHS GROUP INC | 10% Owner | Sale | $22.02 | 672 | $14.80K | 74.87K |
| Aug 5, 26 | GOLDMAN SACHS GROUP INC | 10% Owner | Sale | $22.03 | 6.97K | $153.55K | 67.90K |
| Aug 5, 26 | GOLDMAN SACHS GROUP INC | 10% Owner | Sale | $22.02 | 400 | $8.81K | 67.50K |
| Aug 5, 26 | GOLDMAN SACHS GROUP INC | 10% Owner | Sale | $21.84 | 1.18K | $25.77K | 66.32K |
| Aug 5, 26 | GOLDMAN SACHS GROUP INC | 10% Owner | Sale | $22.05 | 1.04K | $22.93K | 65.28K |
| Aug 5, 26 | GOLDMAN SACHS GROUP INC | 10% Owner | Sale | $20.84 | 300 | $6.25K | 64.98K |
| Aug 5, 26 | GOLDMAN SACHS GROUP INC | 10% Owner | Sale | $21.78 | 443 | $9.65K | 64.54K |
| Aug 5, 26 | GOLDMAN SACHS GROUP INC | 10% Owner | Sale | $22.05 | 200 | $4.41K | 64.34K |
| Aug 5, 26 | GOLDMAN SACHS GROUP INC | 10% Owner | Sale | $22.07 | 700 | $15.45K | 63.64K |
| Aug 5, 26 | GOLDMAN SACHS GROUP INC | 10% Owner | Sale | $22.19 | 1.16K | $25.81K | 62.47K |
| Aug 5, 26 | GOLDMAN SACHS GROUP INC | 10% Owner | Sale | $21.99 | 100 | $2.20K | 62.37K |
| Aug 5, 26 | GOLDMAN SACHS GROUP INC | 10% Owner | Sale | $21.61 | 6.76K | $146.15K | 55.61K |
| Aug 5, 26 | GOLDMAN SACHS GROUP INC | 10% Owner | Sale | $21.04 | 76.42K | $1.61M | -- |
| Aug 6, 26 | GOLDMAN SACHS GROUP INC | 10% Owner | Sale | -- | 18.18M | -- | -- |
| Aug 6, 26 | GOLDMAN SACHS GROUP INC | 10% Owner | Sale | -- | 4.45M | -- | -- |
| Aug 6, 26 | Deep Track Biotechnology Master Fund, Ltd. | 10 percent owner | Purchase | -- | 1.96M | -- | 1.96M |
| Aug 6, 26 | Deep Track Biotechnology Master Fund, Ltd. | 10 percent owner | Sale | -- | 18.18M | -- | -- |
| Aug 6, 26 | venBio Global Strategic Fund IV, L.P. | 10 percent owner | Purchase | $17.00 | 382.35K | $6.50M | 4.18M |
| Aug 6, 26 | venBio Global Strategic Fund IV, L.P. | 10 percent owner | Purchase | -- | 665.15K | -- | 3.80M |
| Aug 6, 26 | venBio Global Strategic Fund IV, L.P. | 10 percent owner | Purchase | -- | 822.00K | -- | 3.13M |
| Aug 6, 26 | venBio Global Strategic Fund IV, L.P. | 10 percent owner | Purchase | -- | 2.31M | -- | 2.31M |
| Aug 6, 26 | venBio Global Strategic Fund IV, L.P. | 10 percent owner | Sale | -- | 21.48M | -- | -- |
| Aug 6, 26 | venBio Global Strategic Fund IV, L.P. | 10 percent owner | Sale | -- | 7.64M | -- | -- |
| Aug 6, 26 | venBio Global Strategic Fund IV, L.P. | 10 percent owner | Sale | -- | 6.18M | -- | -- |
| Aug 6, 26 | Redmile Group, LLC | 10 percent owner | Purchase | $17.00 | 400.00K | $6.80M | 1.18M |
| Aug 6, 26 | Redmile Group, LLC | 10 percent owner | Purchase | $17.00 | 200.00K | $3.40M | 982.85K |
| Aug 6, 26 | Redmile Group, LLC | 10 percent owner | Purchase | -- | 782.85K | -- | 782.85K |
| Aug 6, 26 | Redmile Group, LLC | 10 percent owner | Sale | -- | 782.85K | -- | -- |
| Aug 6, 26 | Sanofi | 10 percent owner | Purchase | $17.00 | 300.00K | $5.10M | 1.08M |
| Aug 6, 26 | Sanofi | 10 percent owner | Purchase | -- | 782.86K | -- | 782.86K |
| Aug 6, 26 | Sanofi | 10 percent owner | Sale | -- | 782.86K | -- | -- |
| Aug 6, 26 | Frazier Life Sciences XI, L.P. | 10 percent owner | Purchase | $17.00 | 588.24K | $10.00M | 6.15M |
| Aug 6, 26 | Frazier Life Sciences XI, L.P. | 10 percent owner | Purchase | -- | 961.32K | -- | 5.57M |
| Aug 6, 26 | Frazier Life Sciences XI, L.P. | 10 percent owner | Purchase | -- | 1.19M | -- | 4.60M |
| Aug 6, 26 | Frazier Life Sciences XI, L.P. | 10 percent owner | Purchase | -- | 1.59M | -- | 3.41M |
| Aug 6, 26 | Frazier Life Sciences XI, L.P. | 10 percent owner | Purchase | -- | 1.75M | -- | 1.82M |
| Aug 6, 26 | Frazier Life Sciences XI, L.P. | 10 percent owner | Sale | -- | 16.25M | -- | -- |
| Aug 6, 26 | Frazier Life Sciences XI, L.P. | 10 percent owner | Sale | -- | 14.77M | -- | -- |
| Aug 6, 26 | Frazier Life Sciences XI, L.P. | 10 percent owner | Sale | -- | 11.05M | -- | -- |
| Aug 6, 26 | Frazier Life Sciences XI, L.P. | 10 percent owner | Sale | -- | 8.93M | -- | -- |
| Aug 4, 26 | You Angie | CTO | Purchase | $17.00 | 27.00K | $459.00K | 27.00K |
| Aug 4, 26 | GOLD MITCHELL | CTO | Purchase | $17.00 | 27.00K | $459.00K | 27.00K |
| Aug 4, 26 | Odrowaz Zaneta | Officer | Purchase | $17.00 | 140.00K | $2.38M | 140.00K |
| Aug 4, 26 | Veiby Petter | Officer | Purchase | $17.00 | 140.00K | $2.38M | 140.00K |
| Aug 4, 26 | Chen Hubert | Officer | Purchase | $17.00 | 140.00K | $2.38M | 140.00K |
| Aug 4, 26 | Attovia Therapeutics, Inc. | CFO | Purchase | $17.00 | 140.00K | $2.38M | 140.00K |
| Aug 4, 26 | Attovia Therapeutics, Inc. | CEO | Purchase | $17.00 | 538.30K | $9.15M | 538.30K |
| Aug 4, 26 | Alamar HoldCo, LLC | 10 percent owner | Sale | -- | -- | -- | 3.23M |
| Aug 4, 26 | WALSH COLIN | CTO | Sale | -- | 1.96M | -- | -- |
| Aug 4, 26 | WALSH COLIN | CTO | Sale | -- | 478.50K | -- | -- |
| Aug 4, 26 | Deep Track Biotechnology Master Fund, Ltd. | 10 percent owner | Sale | -- | 1.96M | -- | -- |
| Aug 4, 26 | Redmile Group, LLC | 10 percent owner | Sale | -- | 782.85K | -- | -- |
| Aug 4, 26 | Vida Ventures GP III, L.L.C. | 10 percent owner | Sale | -- | 2.16K | -- | -- |
| Aug 4, 26 | venBio Global Strategic Fund IV, L.P. | 10 percent owner | Sale | -- | 2.31M | -- | -- |
| Aug 4, 26 | venBio Global Strategic Fund IV, L.P. | 10 percent owner | Sale | -- | 822.00K | -- | -- |
| Aug 4, 26 | venBio Global Strategic Fund IV, L.P. | 10 percent owner | Sale | -- | 665.15K | -- | -- |
| Aug 4, 26 | You Angie | CTO | Sale | -- | -- | -- | 52.85K |
| Aug 4, 26 | You Angie | CTO | Sale | $4.92 | 19.91K | $98.05K | -- |
| Aug 4, 26 | Veiby Petter | Officer | Sale | -- | -- | -- | 104.95K |
| Aug 4, 26 | Veiby Petter | Officer | Sale | $2.88 | 5.38K | $15.50K | -- |
| Aug 4, 26 | Veiby Petter | Officer | Sale | $3.53 | 107.64K | $380.00K | -- |
| Aug 4, 26 | Veiby Petter | Officer | Sale | $4.92 | 89.34K | $439.90K | -- |
| Aug 4, 26 | Veiby Petter | Officer | Sale | $1.58 | 18.84K | $29.75K | -- |
| Aug 4, 26 | Royston Aaron | -- | Sale | -- | -- | -- | -- |
| Aug 4, 26 | Attovia Therapeutics, Inc. | CFO | Sale | $3.53 | 215.28K | $760.00K | -- |
| Aug 4, 26 | Attovia Therapeutics, Inc. | CFO | Sale | $4.92 | 80.73K | $397.50K | -- |
| Aug 4, 26 | Odrowaz Zaneta | Officer | Sale | -- | -- | -- | 103.27K |
| Aug 4, 26 | Odrowaz Zaneta | Officer | Sale | $1.58 | 15.14K | $23.91K | -- |
| Aug 4, 26 | Odrowaz Zaneta | Officer | Sale | $2.88 | 5.38K | $15.50K | -- |
| Aug 4, 26 | Odrowaz Zaneta | Officer | Sale | $3.53 | 102.26K | $361.00K | -- |
| Aug 4, 26 | Odrowaz Zaneta | Officer | Sale | $4.92 | 85.04K | $418.70K | -- |
| Aug 4, 26 | Attovia Therapeutics, Inc. | CEO | Sale | -- | -- | -- | 245.43K |
| Aug 4, 26 | Attovia Therapeutics, Inc. | CEO | Sale | -- | -- | -- | 116.10K |
| Aug 4, 26 | Attovia Therapeutics, Inc. | CEO | Sale | -- | -- | -- | 99.18K |
| Aug 4, 26 | Attovia Therapeutics, Inc. | CEO | Sale | -- | -- | -- | 87.84K |
| Aug 4, 26 | Attovia Therapeutics, Inc. | CEO | Sale | $1.58 | 23.44K | $37.01K | -- |
| Aug 4, 26 | GOLD MITCHELL | CTO | Sale | $3.53 | 52.85K | $186.58K | -- |
| Aug 4, 26 | GOLD MITCHELL | CTO | Sale | $4.92 | 19.91K | $98.05K | -- |
| Aug 4, 26 | Topper James N | -- | Sale | -- | -- | -- | -- |
| Aug 4, 26 | Chen Hubert | Officer | Sale | -- | -- | -- | 2.96K |
| Aug 4, 26 | Chen Hubert | Officer | Sale | $3.53 | 96.88K | $342.00K | -- |
| Aug 4, 26 | Chen Hubert | Officer | Sale | $4.92 | 80.73K | $397.50K | -- |
| Aug 4, 26 | Smither John W | CTO | Sale | $9.29 | 72.79K | $676.24K | -- |
| Aug 4, 26 | Frazier Life Sciences XI, L.P. | 10 percent owner | Sale | -- | -- | -- | 75.35K |
| Aug 4, 26 | Frazier Life Sciences XI, L.P. | 10 percent owner | Sale | -- | 1.75M | -- | -- |
| Aug 4, 26 | Frazier Life Sciences XI, L.P. | 10 percent owner | Sale | -- | 1.59M | -- | -- |
| Aug 4, 26 | Frazier Life Sciences XI, L.P. | 10 percent owner | Sale | -- | 1.19M | -- | -- |
| Aug 4, 26 | Frazier Life Sciences XI, L.P. | 10 percent owner | Sale | -- | 961.32K | -- | -- |
| Aug 4, 26 | GOLDMAN SACHS GROUP INC | 10 percent owner | Sale | -- | 1.96M | -- | -- |
| Aug 4, 26 | GOLDMAN SACHS GROUP INC | 10 percent owner | Sale | -- | 478.50K | -- | -- |
| Aug 4, 26 | Sanofi | 10 percent owner | Sale | -- | 782.86K | -- | -- |